Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW (April 2002). «Dissecting p53 tumor suppressor capabilities in vivo». Arsic N, Gadea G, Lagerqvist EL, Busson M, Cahuzac N, Brock C, Hollande F, Gire V, Pannequin J, Roux P (April 2015). «The p53 isoform Δ133p53β encourages most cancers stem mobile prospective». Khoury MP, Bourdon JC (April 2011). «p53 Isoforms: An Intracellular Microprocessor?». Surget S, Khoury MP, Bourdon JC (December 2013). «Uncovering the purpose of p53 splice variants in human malignancy: a scientific perspective». Thurow HS, Haack R, Hartwig FP, Oliveira IO, Dellagostin OA, Gigante DP, Horta BL, Collares T, Seixas FK (December 2011). «TP53 gene polymorphism: worth to most cancers, ethnicity and birth body weight in a Brazilian cohort». Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC (November 2011). «TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-assessment». Wang XW, Tseng A, Ellis NA, Spillare EA, Linke SP, Robles AI, Seker H, Yang Q, Chaturbate-Asia Hu P, Beresten S, Bemmels NA, Garfield S, Harris CC (August 2001). «Functional conversation of p53 and BLM DNA helicase in apoptosis».
Yang Q, Zhang R, Wang XW, Spillare EA, Linke SP, Subramanian D, Griffith JD, Li JL, Hickson ID, Shen JC, Loeb LA, Mazur SJ, Appella E, Brosh RM, Karmakar P, Bohr VA, Harris CC (August 2002). «The processing of Holliday junctions by BLM and WRN helicases is controlled by p53». Canner JA, Sobo M, Ball S, Hutzen B, DeAngelis S, Willis W, Studebaker AW, Ding K, Wang S, Yang D, Lin J (September 2009). «MI-63: a novel compact-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-variety p53». Marión RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA (August 2009). «A p53-mediated DNA damage response limitations reprogramming to assure iPS mobile genomic integrity». Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L (August 1998). «The necessity for the p53 proline-rich purposeful area for mediation of apoptosis is correlated with certain PIG3 gene transactivation and with transcriptional repression». Han JM, Park BJ, Park SG, Oh YS, Choi SJ, Lee SW, Hwang SK, Chang SH, Cho MH, Kim S (August 2008). «AIMP2/p38, the scaffold for the multi-tRNA synthetase intricate, responds to genotoxic stresses through p53». Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Park SH, Thompson T, Karsenty G, Bradley A, Donehower LA (January 2002). «p53 mutant mice that screen early ageing-involved phenotypes».
Pearson S, Jia H, Kandachi K (January 2004). «China approves first gene treatment». Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, Valle G, Faulkner G (May 2004). «The Ankrd2 protein, a website link among the sarcomere and the nucleus in skeletal muscle». Leu JI, Dumont P, Hafey M, Murphy ME, George DL (May 2004). «Mitochondrial p53 activates Bak and leads to disruption of a Bak-Mcl1 sophisticated». Toufektchan E, Toledo F (May 2018). «The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure». Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P (May 1997). «Genetic interactions among atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints». Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ (December 1997). «p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner». Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R (November 2003). «Regulation of BRCC, a holoenzyme elaborate made up of BRCA1 and BRCA2, by a signalosome-like subunit and its purpose in DNA maintenance». Harms KL, Chen X (March 2005). «The C terminus of p53 relatives proteins is a cell destiny determinant».
AG, SINGULUS Technologies (March 3, 2020). «CD Production Replication Machine». Mitkin NA, Hook CD, Schwartz AM, Biswas S, Kochetkov DV, Muratova AM, Afanasyeva MA, Kravchenko JE, Bhattacharyya A, Kuprash DV (March 2015). «p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast most cancers cells». Assadian S, El-Assaad W, Wang XQ, Gannon PO, Barrès V, Latour M, Mes-Masson AM, Saad F, Sado Y, Dostie J, Teodoro JG (March 2012). «p53 inhibits angiogenesis by inducing the production of Arresten». Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q (September 2011). «Effects of MDM2 promoter polymorphisms and p53 codon seventy two polymorphism on danger and age at onset of squamous mobile carcinoma of the head and neck». Sonoyama T, Sakai A, Mita Y, Yasuda Y, Kawamoto H, Yagi T, Yoshioka M, Mimura T, Nakachi K, Ouchida M, Yamamoto K, Shimizu K (2011). «TP53 codon 72 polymorphism is affiliated with pancreatic cancer danger in males, smokers and drinkers». Due to the isoformic mother nature of p53 proteins, there have been many sources of evidence displaying that mutations in the TP53 gene giving increase to mutated isoforms are causative brokers of a variety of most cancers phenotypes, from gentle to severe, owing to solitary mutation in the TP53 gene (refer to part Experimental assessment of p53 mutations for a lot more specifics).